Dutcher’s work on Chlamydomonas helps home in on disease (Links to an external site)
Personalized medicine centers on being able to predict the risk of disease or response to a drug based on a person’s genetic makeup. But a study by scientists at Washington University School of Medicine in St. Louis suggests that, for most common diseases, genes alone only tell part of the story.
A team led by Michael A. Province, Ph.D., professor of biostatistics and genetics, received a five-year, $4 million grant from the National Institute on Aging (NIA) to establish a Data Management and Coordinating Center (DMCC) for the “Exceptional Longevity Family Study.”